Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study.

Although the overall difference across the four groups was only marginally statistically significant ( P = 0.050; Supplementary Figure S5 ), patients treated with PI-based regimens demonstrated a higher survival probability than patients who received conventional treatments (Bonferroni adjusted P = 0.029).

also in 1,110 other papers